메뉴 건너뛰기




Volumn 138, Issue 6, 2001, Pages 403-

Treatment of hyponatremic encephalopathy

Author keywords

[No Author keywords available]

Indexed keywords

5 FLUORO 2 METHYL N (4 (5H PYRROLO(2,1 C) (1,4)BENZODIAZEPIN 10 (11H) YLCARBONYL) 3 CHLOROPHENYL)BENZAMIDE; 5-FLUORO-2-METHYL-N-(4-(5H-PYRROLO(2,1-C)-(1,4)BENZODIAZEPIN-10-(11H)-YLCARBONYL)-3-CHLOROPHENYL)BENZAMIDE; AZEPINE DERIVATIVE; BENZAMIDE DERIVATIVE; SODIUM CHLORIDE; VASOPRESSIN RECEPTOR;

EID: 0035662117     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2001.119857     Document Type: Letter
Times cited : (2)

References (10)
  • 1
    • 0034957821 scopus 로고    scopus 로고
    • Treatment of hyponatremic encephalopathy with antagonists to antidiuretic hormone
    • (2001) J Lab Clin Med , vol.138 , pp. 8-10
    • Arieff, A.I.1
  • 2
    • 0034962769 scopus 로고    scopus 로고
    • Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985
    • (2001) J Lab Clin Med , vol.138 , pp. 18-21
    • Decaux, G.1
  • 7
    • 0035348291 scopus 로고    scopus 로고
    • Long term treatment of inappropriate secretion of antidiuretic hormone by the vasopressin antagonist conivaptan, urea or furosemide
    • (2001) Am J Med , vol.110 , pp. 582-584
    • Decaux, G.1
  • 8
    • 0029790541 scopus 로고    scopus 로고
    • Therapeutic recommendations for management of severe hyponatremia: Current concepts on pathogenesis and prevention of neurologic complications
    • (1996) Clin Nephrol , vol.46 , pp. 149-169
    • Soupart, A.1    Decaux, G.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.